Metraipolis › archive › dc_491891fec455

A randomised double blind placebo-controlled clinical trial to evaluate the effects of Liv-Pro- a food supplement for Non-Alcoholic Fatty Liver Disease — Europe PMC PMID:41223581

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41223581
DOI
10.1016/j.jaim.2025.101196
License (as archived)
solo-consultazione
Archived
2026-11-08T16:21:30.781Z
SHA-256 of the archived text
1f4b90e283899662ed107bf35f2dd22163813d8b80ff958823100c3b472b1743
Stable URL of this page
https://metraipolis.com/documento/dc_491891fec455

How to cite

A randomised double blind placebo-controlled clinical trial to evaluate the effects of Liv-Pro- a food supplement for Non-Alcoholic Fatty Liver Disease — Europe PMC PMID:41223581 — Europe PMC (en), https://europepmc.org/article/MED/41223581 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_491891fec455 (Metraipolis archive dc_491891fec455, sha256 1f4b90e283899662ed107bf35f2dd22163813d8b80ff958823100c3b472b1743)
BibTeX
@misc{dc491891fec455,
  title = {A randomised double blind placebo-controlled clinical trial to evaluate the effects of Liv-Pro- a food supplement for Non-Alcoholic Fatty Liver Disease — Europe PMC PMID:41223581},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41223581},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_491891fec455; sha256 1f4b90e283899662ed107bf35f2dd22163813d8b80ff958823100c3b472b1743},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41223581. Agents can read the archived copy with the MCP tool read_document.